Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Camera detection and modal fingerprinting of photonic crystal nanobeam resonances.

Afzal FO, Petrin JM, Weiss SM.

Opt Express. 2019 May 13;27(10):14623-14634. doi: 10.1364/OE.27.014623.

PMID:
31163907
2.

A Scoping Review of Modifiable Risk Factors in Pediatric Onset Multiple Sclerosis: Building for the Future.

Pétrin J, Fiander M, Doss PMIA, Yeh EA.

Children (Basel). 2018 Oct 26;5(11). pii: E146. doi: 10.3390/children5110146. Review.

3.

The Experience of Persons With Multiple Sclerosis Using MS INFoRm: An Interactive Fatigue Management Resource.

Pétrin J, Akbar N, Turpin K, Smyth P, Finlayson M.

Qual Health Res. 2018 Apr;28(5):778-788. doi: 10.1177/1049732317753584. Epub 2018 Feb 7.

PMID:
29411682
4.

A pilot mixed-methods evaluation of MS INFoRm: a self-directed fatigue management resource for individuals with multiple sclerosis.

Akbar N, Turpin K, Petrin J, Smyth P, Finlayson M.

Int J Rehabil Res. 2018 Jun;41(2):114-121. doi: 10.1097/MRR.0000000000000271.

PMID:
29324506
5.

Exercise interventions in multiple sclerosis rehabilitation need better reporting on comorbidities: a systematic scoping review.

Bisson EJ, Fakolade A, Pétrin J, Lamarre J, Finlayson M.

Clin Rehabil. 2017 Oct;31(10):1305-1312. doi: 10.1177/0269215517698734. Epub 2017 Mar 14.

PMID:
28933610
6.

Effect of Comorbidities on Outcomes of Neurorehabilitation Interventions in Multiple Sclerosis: A Scoping Review.

Fakolade A, Bisson EJ, Pétrin J, Lamarre J, Finlayson M.

Int J MS Care. 2016 Nov-Dec;18(6):282-290. doi: 10.7224/1537-2073.2016-015.

7.

Aminoglycoside resistance genes aph(2")-Ib and aac(6')-Im detected together in strains of both Escherichia coli and Enterococcus faecium.

Chow JW, Kak V, You I, Kao SJ, Petrin J, Clewell DB, Lerner SA, Miller GH, Shaw KJ.

Antimicrob Agents Chemother. 2001 Oct;45(10):2691-4.

8.

Detection of the high-level aminoglycoside resistance gene aph(2")-Ib in Enterococcus faecium.

Kao SJ, You I, Clewell DB, Donabedian SM, Zervos MJ, Petrin J, Shaw KJ, Chow JW.

Antimicrob Agents Chemother. 2000 Oct;44(10):2876-9.

9.

Inhibitors of farnesyl protein transferase. 4-Amido, 4-carbamoyl, and 4-carboxamido derivatives of 1-(8-chloro-6,11-dihydro-5H-benzo[5,6]- cyclohepta[1,2-b]pyridin-11-yl)piperazine and 1-(3-bromo-8-chloro-6,11- dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-yl)piperazine.

Mallams AK, Rossman RR, Doll RJ, Girijavallabhan VM, Ganguly AK, Petrin J, Wang L, Patton R, Bishop WR, Carr DM, Kirschmeier P, Catino JJ, Bryant MS, Chen KJ, Korfmacher WA, Nardo C, Wang S, Nomeir AA, Lin CC, Li Z, Chen J, Lee S, Dell J, Lipari P, Liu M, et al.

J Med Chem. 1998 Mar 12;41(6):877-93.

PMID:
9526562
10.

A new variant of trichothiodystrophy with recurrent infections, failure to thrive, and death.

Petrin JH, Meckler KA, Sybert VP.

Pediatr Dermatol. 1998 Jan-Feb;15(1):31-4.

PMID:
9496800
11.

Structure-activity relationship of 3-substituted N-(pyridinylacetyl)-4- (8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene )- piperidine inhibitors of farnesyl-protein transferase: design and synthesis of in vivo active antitumor compounds.

Njoroge FG, Vibulbhan B, Rane DF, Bishop WR, Petrin J, Patton R, Bryant MS, Chen KJ, Nomeir AA, Lin CC, Liu M, King I, Chen J, Lee S, Yaremko B, Dell J, Lipari P, Malkowski M, Li Z, Catino J, Doll RJ, Girijavallabhan V, Ganguly AK.

J Med Chem. 1997 Dec 19;40(26):4290-301.

PMID:
9435898
12.

Discovery of novel nonpeptide tricyclic inhibitors of Ras farnesyl protein transferase.

Njoroge FG, Doll RJ, Vibulbhan B, Alvarez CS, Bishop WR, Petrin J, Kirschmeier P, Carruthers NI, Wong JK, Albanese MM, Piwinski JJ, Catino J, Girijavallabhan V, Ganguly AK.

Bioorg Med Chem. 1997 Jan;5(1):101-13.

PMID:
9043662
13.

Antitumor 8-chlorobenzocycloheptapyridines: a new class of selective, nonpeptidic, nonsulfhydryl inhibitors of ras farnesylation.

Mallams AK, Njoroge FG, Doll RJ, Snow ME, Kaminski JJ, Rossman RR, Vibulbhan B, Bishop WR, Kirschmeier P, Liu M, Bryant MS, Alvarez C, Carr D, James L, King I, Li Z, Lin CC, Nardo C, Petrin J, Remiszewski SW, Taveras AG, Wang S, Wong J, Catino J, Ganguly AK, et al.

Bioorg Med Chem. 1997 Jan;5(1):93-9.

PMID:
9043661
14.

Effects of increased arterial epinephrine on insulin, glucose and phosphate.

Kjeldsen SE, Moan A, Petrin J, Weder AB, Julius S.

Blood Press. 1996 Jan;5(1):27-31.

PMID:
8777469
15.

Novel tricyclic inhibitors of farnesyl protein transferase. Biochemical characterization and inhibition of Ras modification in transfected Cos cells.

Bishop WR, Bond R, Petrin J, Wang L, Patton R, Doll R, Njoroge G, Catino J, Schwartz J, Windsor W, et al.

J Biol Chem. 1995 Dec 22;270(51):30611-8.

16.
17.

Characterization of site-specific mutants altered at protein kinase C beta 1 isozyme autophosphorylation sites.

Zhang J, Wang L, Petrin J, Bishop WR, Bond RW.

Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6130-4.

18.

The dissociation of arterial hypertension and lupus glomerulonephritis in systemic lupus erythematosus.

Petrin J, Rozman B, Dolenc P, Logar D, Bozic B, Vizjak A, Ferluga D, Jezersek P.

Blood Press. 1993 Jun;2(2):108-12.

PMID:
8180722
19.

Contrasting effects of epinephrine on forearm hemodynamics and arterial plasma norepinephrine.

Kjeldsen SE, Petrin J, Weder AB, Julius S.

Am J Hypertens. 1993 May;6(5 Pt 1):369-75.

PMID:
8512661
20.

Evaluation of self-measured home vs. clinic intra-arterial blood pressure.

Kjeldsen SE, Moan A, Petrin J, Weder AB, Zweifler AJ, Julius S.

Blood Press. 1993 Mar;2(1):28-34.

PMID:
8193727
22.

NaCl induces differential changes of regional vascular reactivity in salt-sensitive versus salt-resistant men.

Egan BM, Petrin J, Hoffmann RG.

Am J Hypertens. 1991 Dec;4(12 Pt 1):924-31.

PMID:
1815648
23.

Neurohumoral and metabolic effects of short-term dietary NaCl restriction in men. Relationship to salt-sensitivity status.

Egan BM, Weder AB, Petrin J, Hoffman RG.

Am J Hypertens. 1991 May;4(5 Pt 1):416-21.

PMID:
1676891
24.

Hyperkinetic borderline hypertension in Tecumseh, Michigan.

Julius S, Krause L, Schork NJ, Mejia AD, Jones KA, van de Ven C, Johnson EH, Sekkarie MA, Kjeldsen SE, Petrin J, et al.

J Hypertens. 1991 Jan;9(1):77-84.

PMID:
1848264
25.

"White coat" versus "sustained" borderline hypertension in Tecumseh, Michigan.

Julius S, Mejia A, Jones K, Krause L, Schork N, van de Ven C, Johnson E, Petrin J, Sekkarie MA, Kjeldsen SE, et al.

Hypertension. 1990 Dec;16(6):617-23.

PMID:
2246029
26.

Inhibition of protein kinase C by the tyrosine kinase inhibitor erbstatin.

Bishop WR, Petrin J, Wang L, Ramesh U, Doll RJ.

Biochem Pharmacol. 1990 Nov 1;40(9):2129-35.

PMID:
2242040
28.

Increased beta-adrenergic tone enhances arterial compliance in hyperkinetic borderline hypertension.

Petrin J, Egan BM, Julius S.

J Hypertens Suppl. 1989 Dec;7(6):S78-9.

PMID:
2561152

Supplemental Content

Loading ...
Support Center